Rates and risk factors for hepatitis B reactivation in a cohort of persons in the inactive phase of chronic hepatitis B-Alaska, 2001-2010.
about
Hepatitis B Reactivation During Immunosuppressive Therapy or Cancer Chemotherapy, Management, and Prevention: A Comprehensive Review-ScreenedNested case-control study: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance.Prognostic values of fluctuations in serum levels of alanine transaminase in inactive carrier state of HBV infection.A new model mimicking persistent HBV e antigen-negative infection using covalently closed circular DNA in immunocompetent mice.Hepatitis B virus genetic mutations and evolution in liver diseases.AASLD guidelines for treatment of chronic hepatitis B.Association of Mutations in the Basal Core Promoter and Pre-core Regions of the Hepatitis B Viral Genome and Longitudinal Changes in HBV Level in HBeAg Negative Individuals: Results From a Cohort Study in Northern IranHepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions.Distribution of disease phase, treatment prescription and severe liver disease among 1598 patients with chronic hepatitis B in the Chronic Hepatitis Cohort Study, 2006-2013.Cost-effectiveness of active-passive prophylaxis and antiviral prophylaxis during pregnancy to prevent perinatal hepatitis B virus infection.Current Condition of Chronic Hepatitis B Virus Infection in Cuban Adults.Prophylactic effect of lamivudine on chemotherapy-induced hepatitis B virus reactivation in patients with solid tumour: A meta-analysis.
P2860
Q28076703-9D644D41-DF25-4161-9721-7E45567CAC28Q30152115-F516827E-278C-41BC-BE51-08198B09DEE7Q33580037-1F69ABA6-B496-42BE-9586-7F44B2911997Q33585283-62771F45-6B25-495F-99F7-D354840D4A5CQ33594925-45971E2C-E8A9-49F4-9FFB-146062A17359Q34501660-1A57C0CE-C431-4516-8153-287E0799AF6EQ35149306-7C0E467B-62C1-4E33-9144-F7887851655FQ38755178-9BA7C610-5EB1-4879-9A4F-AF5D90556D49Q39377075-DD119A1A-1FBE-4A16-98FE-E2DA1AF87A06Q40934257-BDFB282B-3BC3-4E67-822C-D00B4214C52FQ45324539-D1A45799-98FA-4708-9DFA-76FDCEB259A6Q47562286-3C73B505-2D0F-486F-B3AB-A5C001334070
P2860
Rates and risk factors for hepatitis B reactivation in a cohort of persons in the inactive phase of chronic hepatitis B-Alaska, 2001-2010.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Rates and risk factors for hep ...... hepatitis B-Alaska, 2001-2010.
@ast
Rates and risk factors for hep ...... hepatitis B-Alaska, 2001-2010.
@en
type
label
Rates and risk factors for hep ...... hepatitis B-Alaska, 2001-2010.
@ast
Rates and risk factors for hep ...... hepatitis B-Alaska, 2001-2010.
@en
prefLabel
Rates and risk factors for hep ...... hepatitis B-Alaska, 2001-2010.
@ast
Rates and risk factors for hep ...... hepatitis B-Alaska, 2001-2010.
@en
P2093
P2860
P1476
Rates and risk factors for hep ...... hepatitis B-Alaska, 2001-2010.
@en
P2093
Brian J McMahon
Chriss E Homan
Lisa Bulkow
Rania A Tohme
Susan Negus
P2860
P304
P356
10.1016/J.JCV.2013.08.012
P577
2013-08-16T00:00:00Z